Atlas Trials

Phase I/II Clinical Study of 1A46 Drug Substance

Clinical trial NCT05987605 · TERMINATED

Trial details

NCT number
NCT05987605
Sponsor
BioRay Pharmaceutical Co., Ltd.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Malignancies
Start date
2023-09-12
Primary completion
2024-08-20
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.